The degree of protection conferred by G6PD Med against P. vivax illness estimated in this study is large; it is similar in magnitude to the well-described protection conferred by Hb AS (sickle cell heterozygotes) against falciparum malaria (Williams et al., 2005). This evidence concerns the gene GSTM1 and Plasmodium falciparum malaria.